首页 正文

Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients

{{output}}
Background: Recent advancements in identifying druggable molecular drivers in lung adenocarcinoma (LUAD), have transformed treatment paradigms. In recent years, Next Generation Sequencing (NGS) has gained momentum as an essential... ...